Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| LFUS | Chu Maggie | SVP, CHRO | 03.09.2026 | Zuteilung | 414,24 | 5 | 2.071 | Form 4 |
| LFUS | Khandelwal Abhishek | Executive VP, CFO | 03.09.2026 | Zuteilung | 414,24 | 15 | 6.214 | Form 4 |
| LFUS | D'Angelo Anne-Marie W | SVP & CLO | 03.09.2026 | Zuteilung | 414,24 | 3 | 1.243 | Form 4 |
| LFUS | Gorski Jeffrey G | SVP & Chief Accounting Officer | 03.09.2026 | Zuteilung | 414,24 | 1 | 414 | Form 4 |
| LFUS | Cerniglia Kristina A. | Director | 03.09.2026 | Zuteilung | 414,24 | 1 | 414 | Form 4 |
| LFUS | Henderson Gregory N. | President & CEO | 03.09.2026 | Zuteilung | 414,24 | 30 | 12.427 | Form 4 |
| LFUS | Nayar Deepak | SVP & GM Electronics Business | 03.09.2026 | Zuteilung | 414,24 | 8 | 3.314 | Form 4 |
| LFUS | Green Maria C | Director | 03.09.2026 | Zuteilung | 414,24 | 3 | 1.243 | Form 4 |
| LFUS | Kelsey Todd P. | Director | 03.09.2026 | Zuteilung | 414,24 | 1 | 414 | Form 4 |
| LFUS | Chung T J | Director | 03.09.2026 | Zuteilung | 414,24 | 1 | 414 | Form 4 |
| LFUS | Chung T J | Director | 03.09.2026 | Zuteilung | 414,24 | 17 | 7.042 | Form 4 |
| LFUS | Noglows William P | Director | 03.09.2026 | Zuteilung | 414,24 | 1 | 414 | Form 4 |
| LFUS | Noglows William P | Director | 03.09.2026 | Zuteilung | 414,24 | 6 | 2.485 | Form 4 |
| LFUS | Hunter Gordon | Director | 03.09.2026 | Zuteilung | 414,24 | 1 | 414 | Form 4 |
| LFUS | Hunter Gordon | Director | 03.09.2026 | Zuteilung | 414,24 | 7 | 2.900 | Form 4 |
| LFUS | Grillo Anthony | Director | 03.09.2026 | Zuteilung | 414,24 | 3 | 1.243 | Form 4 |
| LFUS | Grillo Anthony | Director | 03.09.2026 | Zuteilung | 414,24 | 58 | 24.026 | Form 4 |
| LGND | Reardon Andrew | CLO & Secretary | 03.09.2026 | Verkauf | 288,98 | 400 | 115.592 | Form 4 |
| LGND | Reardon Andrew | CLO & Secretary | 03.09.2026 | Verkauf | 287,53 | 385 | 110.697 | Form 4 |
| LGND | Reardon Andrew | CLO & Secretary | 03.09.2026 | Verkauf | 286,36 | 2.115 | 605.649 | Form 4 |
| LGND | Reardon Andrew | CLO & Secretary | 03.09.2026 | Verkauf | 285,17 | 1.800 | 513.301 | Form 4 |
| LGND | Reardon Andrew | CLO & Secretary | 03.09.2026 | Verkauf | 283,99 | 300 | 85.196 | Form 4 |
| LITE | Wupen Yuen | PRESIDENT, GLOBAL BUS. UNITS | 03.09.2026 | Verkauf | 870,01 | 500 | 435.005 | Form 4 |
| LAES | Enguent Jean-Pierre | Vice President, R&DSS | 03.09.2026 | Verkauf | 2,40 | 15.000 | 36.030 | Form 4 |
| LIDR | Tierney Conor B | Treasurer & CFO | 02.09.2026 | Zuteilung | — | 100.000 | — | Form 4 |
| LITE | Wupen Yuen | PRESIDENT, GLOBAL BUS. UNITS | 02.09.2026 | Verkauf | 864,49 | 500 | 432.245 | Form 4 |
| LFST | Bourdon David | Chief Executive Officer | 02.09.2026 | J | — | 150.000 | — | Form 4 |
| LFST | Paunovich Vukasin | Chief Technology Officer | 02.09.2026 | Verkauf | 12,87 | 42.067 | 541.402 | Form 4 |
| LILAK | De Angoitia Alfonso | Director | 02.09.2026 | Kauf | 20,95 | 313.104 | 6.559.873 | Form 4 |
| LILA | De Angoitia Alfonso | Director | 02.09.2026 | Kauf | 20,95 | 313.104 | 6.559.873 | Form 4 |
| LMND | Wininger Shai | President | 02.09.2026 | Schenkung | — | 1.876 | — | Form 4 |
| LNTH | Lantheus Alpha Therapy, LLC | 10% Owner | 02.09.2026 | Verkauf | 3,11 | 42.129 | 131.219 | Form 4 |
| LLY | Dozier Eric | EVP, Chief People Officer | 02.09.2026 | Schenkung | — | 216 | — | Form 4 |
| LLY | Hernandez Edgardo | EVP & Pres., Mfg. Operations | 02.09.2026 | Schenkung | — | 13 | — | Form 4 |
| LOB | Williams William L. Iii | Director | 02.09.2026 | Verkauf | 40,00 | 1.810 | 72.401 | Form 4 |
| LOB | Mahan James S Iii | Chief Executive Officer | 02.09.2026 | Verkauf | 39,88 | 258 | 10.288 | Form 4 |
| LOB | Mahan James S Iii | Chief Executive Officer | 02.09.2026 | Verkauf | 39,53 | 9.742 | 385.124 | Form 4 |
| LAUR | Snow Ian Kendell | Director | 02.09.2026 | Verkauf | 36,26 | 427.019 | 15.482.556 | Form 4 |
| LRCX | Varadarajan Seshasayee | Senior Vice President | 02.09.2026 | Verkauf | 291,32 | 27.480 | 8.005.474 | Form 4 |
| LRCX | Varadarajan Seshasayee | Senior Vice President | 02.09.2026 | Optionsausübung | 30,03 | 27.480 | 825.307 | Form 4 |
| LRCX | Varadarajan Seshasayee | Senior Vice President | 02.09.2026 | Verkauf | 291,32 | 12.270 | 3.574.496 | Form 4 |
| LRCX | Varadarajan Seshasayee | Senior Vice President | 02.09.2026 | Optionsausübung | 59,88 | 12.270 | 734.740 | Form 4 |
| LRCX | Varadarajan Seshasayee | Senior Vice President | 02.09.2026 | Verkauf | 291,32 | 20.000 | 5.826.400 | Form 4 |
| LCUT | Siegel Jeffrey | Director | 02.09.2026 | Verkauf | 9,50 | 193 | 1.834 | Form 4 |
| LPA | Marquina Javier | Director | 01.09.2026 | Verkauf | 3,09 | 1.800 | 5.562 | Form 4 |
| LILAK | De Angoitia Alfonso | Director | 01.09.2026 | Kauf | 20,65 | 17.596 | 363.340 | Form 4 |
| LILA | De Angoitia Alfonso | Director | 01.09.2026 | Kauf | 20,65 | 17.596 | 363.340 | Form 4 |
| LAES | Enguent Jean-Pierre | Vice President, R&DSS | 01.09.2026 | Optionsausübung | 0,01 | 15.000 | 150 | Form 4 |
| LUNG | Radhakrishnan Srikanth | Chief Science & Techn. Officer | 01.09.2026 | Verkauf | 2,26 | 5.863 | 13.250 | Form 4 |
| LUNG | Radhakrishnan Srikanth | Chief Science & Techn. Officer | 01.09.2026 | Verkauf | 2,26 | 3.618 | 8.177 | Form 4 |
| LUNG | Radhakrishnan Srikanth | Chief Science & Techn. Officer | 01.09.2026 | Verkauf | 2,26 | 2.121 | 4.793 | Form 4 |
| LUNG | Radhakrishnan Srikanth | Chief Science & Techn. Officer | 01.09.2026 | Verkauf | 2,26 | 2.643 | 5.973 | Form 4 |
| LUNG | French Glendon E. III | President and CEO | 01.09.2026 | Verkauf | 2,26 | 37.784 | 85.392 | Form 4 |
| LUNG | French Glendon E. III | President and CEO | 01.09.2026 | Verkauf | 2,26 | 4.098 | 9.261 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 01.09.2026 | Verkauf | 2,26 | 1.746 | 3.946 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 01.09.2026 | Verkauf | 2,26 | 1.530 | 3.458 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 01.09.2026 | Verkauf | 2,26 | 2.390 | 5.401 | Form 4 |
| LUNG | Rose Geoffrey Beran | Chief Commercial Officer | 01.09.2026 | Verkauf | 2,26 | 2.213 | 5.001 | Form 4 |
| LUNG | Lehman David Aaron | General Counsel | 01.09.2026 | Verkauf | 2,26 | 4.827 | 10.909 | Form 4 |
| LUNG | Lehman David Aaron | General Counsel | 01.09.2026 | Verkauf | 2,26 | 3.476 | 7.856 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).